Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Assembly Biosciences (ASMB) Change in Acquisitions & Divestments: 2015-2025

Historic Change in Acquisitions & Divestments for Assembly Biosciences (ASMB) over the last 10 years, with Sep 2025 value amounting to $22.7 million.

  • Assembly Biosciences' Change in Acquisitions & Divestments fell 42.09% to $22.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $117.8 million, marking a year-over-year increase of 2.28%. This contributed to the annual value of $130.7 million for FY2024, which is 101.03% up from last year.
  • Per Assembly Biosciences' latest filing, its Change in Acquisitions & Divestments stood at $22.7 million for Q3 2025, which was down 34.20% from $34.5 million recorded in Q2 2025.
  • Over the past 5 years, Assembly Biosciences' Change in Acquisitions & Divestments peaked at $66.5 million during Q1 2021, and registered a low of $10.0 million during Q1 2023.
  • Its 3-year average for Change in Acquisitions & Divestments is $25.4 million, with a median of $22.7 million in 2025.
  • Its Change in Acquisitions & Divestments has fluctuated over the past 5 years, first plummeted by 66.67% in 2023, then surged by 147.87% in 2024.
  • Quarterly analysis of 5 years shows Assembly Biosciences' Change in Acquisitions & Divestments stood at $43.0 million in 2021, then plummeted by 48.84% to $22.0 million in 2022, then declined by 15.00% to $18.7 million in 2023, then surged by 82.89% to $34.2 million in 2024, then tumbled by 42.09% to $22.7 million in 2025.
  • Its Change in Acquisitions & Divestments was $22.7 million in Q3 2025, compared to $34.5 million in Q2 2025 and $26.4 million in Q1 2025.